ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

NIH RPG Success Rate to Fall Further

June 7, 2013

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992